BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8885849)

  • 21. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
    Nakatani K; Horie S; Goto Y; Kobori A; Hagihara S
    Bioorg Med Chem; 2006 Aug; 14(15):5384-8. PubMed ID: 16603366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Daly TJ; Cook KS; Gray GS; Maione TE; Rusche JR
    Nature; 1989 Dec; 342(6251):816-9. PubMed ID: 2481237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
    West ML; Ramsdale TE
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S; Reddy TR
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.
    Mills NL; Daugherty MD; Frankel AD; Guy RK
    J Am Chem Soc; 2006 Mar; 128(11):3496-7. PubMed ID: 16536504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein.
    Schoborg RV; Clements JE
    Virology; 1996 Dec; 226(1):113-21. PubMed ID: 8941328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric inhibition of the HIV-1 Rev/RRE interaction by a 3'-methylphosphonate modified antisense oligo-2'-O-methylribonucleotide.
    Prater CE; Saleh AD; Wear MP; Miller PS
    Oligonucleotides; 2007; 17(3):275-90. PubMed ID: 17854268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
    Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
    J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
    Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
    Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules.
    Fineberg K; Fineberg T; Graessmann A; Luedtke NW; Tor Y; Lixin R; Jans DA; Loyter A
    Biochemistry; 2003 Mar; 42(9):2625-33. PubMed ID: 12614157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
    Pallesen J; Dong M; Besenbacher F; Kjems J
    FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
    Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
    Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 replication by targeting the Rev protein.
    Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
    Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affinity purification of a correctly folded fragment of synthetic HIV-1 mRNA using a HIV-1 Rev peptide-ligand.
    Englebretsen DR; Scanlon MJ; West ML
    Biomed Pept Proteins Nucleic Acids; 1996; 2(2):47-50. PubMed ID: 9346826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression.
    Dangerfield JA; Hohenadl C; Egerbacher M; Kodajova P; Salmons B; Günzburg WH
    Gene; 2005 Sep; 358():17-30. PubMed ID: 16023306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression.
    Mann DA; Mikaélian I; Zemmel RW; Green SM; Lowe AD; Kimura T; Singh M; Butler PJ; Gait MJ; Karn J
    J Mol Biol; 1994 Aug; 241(2):193-207. PubMed ID: 8057359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.